Evidence map›Paper›PMID 31211179›Full record

ArticleAnnals of clinical and translational neurology2019

CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis.

Marc Pawlitzki, Michaela Butryn, Florian Kirchner, Jacqueline Färber, Oliver Beuing, Jens Minnerup, Sven G Meuth, Jens Neumann

Abstract readCase Reports
In one paragraph

Article in Annals of clinical and translational neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marc PawlitzkiDepartment of Neurology Otto-von-Guericke University Leipziger Straße 44 39120 Magdeburg Germany.ORCID https://orcid.org/0000-0003-3080-2277
Michaela ButrynDepartment of Neurology Otto-von-Guericke University Leipziger Straße 44 39120 Magdeburg Germany.
Florian KirchnerDepartment of Neurology AMEOS Klinikum Bernburg Kustrenaer Str. 98 06406 Bernburg Germany.
Jacqueline FärberInstitute of Medical Microbiology Infection Control and Prevention Otto-von-Guericke University Leipziger Straße 44 39120 Magdeburg Germany.
Oliver BeuingDepartment of Neuroradiology Otto-von-Guericke University Leipziger Straße 44 39120 Magdeburg Germany.
Jens MinnerupDepartment of Neurology with Institute of Translational Neurology Albert-Schweitzer-Campus 1 48149 Münster Germany.
Sven G MeuthDepartment of Neurology with Institute of Translational Neurology Albert-Schweitzer-Campus 1 48149 Münster Germany.
Jens NeumannDepartment of Neurology Otto-von-Guericke University Leipziger Straße 44 39120 Magdeburg Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rarity of primary angiitis of the central nervous system (PACNS) demands diagnostic and prognostic biomarkers. We retrospectively measured Neurofilament light chain (NFL) concentrations in cerebrospinal fluid in a severely relapsing PACNS patient at multiple time points during the course of the disease. A marked increase in NFL levels preceding the onset of neuro-axonal damage and arterial-vessel abnormalities was observed with magnetic resonance imaging as well as with MR- and conventional angiography. Thus, marked elevation of NFL in PACNS seems to occur ahead of definitive radiological abnormalities and might serve as a diagnostic biomarker.

Indexed as

AdultAxonsBiomarkersBrainCerebral AngiographyCerebrospinal FluidHumansMaleNeurofilament ProteinsRetrospective StudiesStrokeVasculitis, Central Nervous SystemBiomarkersNeurofilament Proteins

Identifiers

PMID31211179
PMCPMC6562033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.